|
Back to Home » March 2020 News » C² PHARMA Opens Government and Research Access to Safety Stock of DIGOXIN API for Use in Potential COVID-19 Combination Treatment |
C² PHARMA Opens Government and Research Access to Safety Stock of DIGOXIN API for Use in Potential COVID-19 Combination Treatment |
March 27, 2020
LUXEMBOURG, March 26, 2020 /PRNewswire/ -- C2 PHARMA s.a.r.l. (C2P), a Luxembourg-based phytochemical and chemical pharmaceutical manufacturing and distribution group, is announcing that they will open access to safety stocks of the active pharmaceutical ingredient (API), Digoxin. In...
Source URL: https://www.prnewswire.com:443/news-releases/c-pharma-opens-government-and-research-access-to-safety-stock-of-digoxin-api-for-use-in-potential-covid-19-combination-treatment-301030689.html
|
|
|
|
